Peer to Peer

Using Patch Testing to Identify Culprit Agents in Suspected Drug Eruptions

Publish date: February 7, 2017

By

Susan T. Nedorost, MD

In this edition of the "Peer to Peer" audiocast series, Dr. Vincent DeLeo speaks with Dr. Susan T. Nedorost about using patch testing as a diagnostic tool for suspected drug eruptions. Dr. Nedorost discusses challenges dermatologists may encounter when using patch testing in cohorts that present with potential drug eruptions and describes settings in which this technique may be most useful for patients. She also emphasizes that drug reactions sometimes may be caused by the product's excipients, not the drug itself.

Recommended Reading

Most Common Dermatologic Conditions Encountered by Dermatologists and Nondermatologists

MDedge Dermatology

Cholinergic Urticaria With Anaphylaxis: Hazardous Duty of a Deployed US Marine

MDedge Dermatology

Mycoplasma pneumoniae Infection in Adults With Acute and Chronic Urticaria

MDedge Dermatology

Pruritic Urticarial Papules and Plaques of Pregnancy Occurring Postpartum

MDedge Dermatology

Dermatologic Emergencies

MDedge Dermatology

Manage Your Dermatology Practice: Answering Patient Questions About Diet

MDedge Dermatology

Diagnosis and Management of Cold Urticaria

MDedge Dermatology

Dermatologists Should Get the Point: Acupuncture for the Treatment of Skin Disorders

MDedge Dermatology

Tryptase gene variant linked to GI, joint, and skin symptoms

MDedge Dermatology

Don’t miss these drug reactions

MDedge Dermatology